Sugammadex(CAS: 343306-71-8)

Sugammadex is a beta-cyclodextrin derivative with a molecular weight of approximately 1200 g/mol. It is poorly soluble in water but soluble in ethanol. Sugammadex is highly reactive due to its beta-cyclodextrin structure, which can form inclusion complexes with various substances. It is a crystalline solid at room temperature.

Sugammadex is synthesized through a multistep process involving the cyclodimerization of gamma-cyclodextrin in the presence of a catalyst, such as ethylene glycol. The process also includes protecting group methodologies to control the cyclodimerization reaction. The overall yield is around 50-70%.

Sugammadex is primarily used in the pharmaceutical industry for the reversal of neuromuscular blockade induced by non-depolarizing muscle relaxants. It has limited applications in other industries as it is specifically developed and approved for clinical use.

When handling Sugammadex, it is important to wear appropriate personal protective equipment (PPE), such as gloves and safety glasses. Work should be conducted in a fume hood to minimize inhalation risks. Spills should be cleaned up using standard spill procedures, and the storage area should be well-ventilated. Always refer to the safety data sheet (SDS) for detailed handling instructions and emergency procedures.